When evaluating research peptides for cellular bioenergetics versus neuroendocrine signaling, investigators frequently encounter distinct peptide classes with specialized molecular targets. This comparative guide analyzes SS-31 (Elamipretide) and Melanotan 1 (Afamelanotide), detailing their structural differences, receptor affinity, preclinical literature, and laboratory protocols.
When evaluating research peptides for cellular bioenergetics versus neuroendocrine signaling, investigators frequently encounter distinct peptide classes with specialized molecular targets. This comparative guide analyzes SS-31 (Elamipretide) and Melanotan 1 (Afamelanotide), detailing their structural differences, receptor affinity, preclinical literature, and laboratory protocols.
SS-31 (Elamipretide) is a synthetic tetrapeptide that selectively targets cardiolipin on the inner mitochondrial membrane to restore bioenergetics and mitigate oxidative stress. In contrast, Melanotan 1 (Afamelanotide) is a synthetic melanocortin analog studied for melanocortin activity related to skin pigmentation responses. They share no structural, receptor, or functional overlap in preclinical models.
Because these two compounds operate through entirely divergent pathways—mitochondrial inner membrane stabilization versus peripheral melanocortin receptor activation—investigators must align their target compound choice precisely with their experimental hypotheses. Below is an analytical overview of the physical and biochemical properties of both compounds verified across preclinical literature.
To assist research laboratories in selecting the appropriate reference standard, the following criteria summarize the baseline physicochemical and experimental parameters of SS-31 and Melanotan 1:
• Receptor Target: Cardiolipin on Inner Mitochondrial Membrane (SS-31) vs Melanocortin Receptors (MC1R/MC3R/MC4R/MC5R) (Melanotan 1) • Mechanistic Class: Small-molecule mitochondrial targeted tetrapeptide (SS-31) vs Synthetic alpha-MSH melanocortin analog (Melanotan 1) • Reported Preclinical Half-Life: ~2 to 4 hours in rodent plasma models (SS-31) vs ~30 to 60 minutes in plasma (Melanotan 1) • Solubility: Highly soluble in sterile water and PBS (SS-31) vs Soluble in sterile water, PBS, and mild acetic acid buffer (Melanotan 1) • Typical Preclinical Models: Ischemia-reperfusion, heart failure, renal damage, neurodegeneration (SS-31) vs UV-induced photo-damage, melanogenesis, dermatological injury models (Melanotan 1) • Standard Lyophilized Vial Sizes Available: 10mg, 20mg, 50mg reference vials via the complete PX1 all peptides research catalog.
Researchers evaluating these reference compounds can verify lot-specific purity and physical constants by checking our published COA repository prior to protocol initiation.
SS-31, also known in scientific literature as Elamipretide or Bendavia, is a water-soluble, aromatic-cationic tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2). Preclinical studies suggest that SS-31 freely penetrates cell membranes and concentrates thousands-fold within the inner mitochondrial membrane (IMM). Rather than binding to a traditional G-protein coupled receptor (GPCR) or cell-surface receptor, SS-31 engages in specific electrostatic and hydrophobic interactions with cardiolipin.
Cardiolipin is an essential phospholipid unique to the IMM that organizes electron transport chain (ETC) complexes into functional supercomplexes (respirasomes). Under conditions of cellular stress or ischemia, cardiolipin undergoes peroxidation by cytochrome c, leading to supercomplex destabilization, increased electron leakage, excess reactive oxygen species (ROS) generation, and compromised ATP synthesis.
In vitro data indicate that when SS-31 selectively binds to cardiolipin, it prevents structural unfolding of cytochrome c, inhibits peroxidase activity, preserves supercomplex integrity, and optimizes mitochondrial ATP production without disrupting normal physiological oxidative signaling. This unique mechanism makes SS-31 a primary subject in studies examining renal ischemia-reperfusion, microvascular injury, cardiotoxicity, and age-related mitochondrial dysfunction.
Melanotan 1 (Afamelanotide, [Ac-Ser-Tyr-Ser-Met-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2]) is a synthetic peptide analog of endogenous alpha-melanocyte-stimulating hormone (α-MSH). Melanotan 1 was engineered to prolong biological activity and increase receptor affinity compared to naturally occurring α-MSH by replacing native residues with D-phenylalanine at position 7.
The primary mechanism of Melanotan 1 involves potent agonist activity across the melanocortin receptor family, demonstrating high selectivity for the melanocortin-1 receptor (MC1R) located on epidermal melanocytes. Agonism of MC1R stimulates intracellular adenylate cyclase, elevating cyclic adenosine monophosphate (cAMP) levels. This cascade upregulates transcription factors such as microphthalmia-associated transcription factor (MITF), driving the synthesis of eumelanin.
Consequently, Melanotan 1 is researched for melanocortin activity related to skin pigmentation responses and photo-protective mechanisms in cellular and animal models. Preclinical studies also investigate secondary interactions with MC3R and MC4R, which modulate central inflammatory pathways and energy homeostasis, though its primary experimental utility remains centered on melanogenesis and photobiology.
Understanding the pharmacokinetics of research peptides in animal models is critical for establishing dosing intervals, tissue exposure, and metabolic clearance profiles during protocol design.
In rodent models, SS-31 exhibits rapid systemic distribution following parenteral administration, with a reported terminal elimination half-life ranging between 2 to 4 hours in rodent plasma. Due to its positive charge and affinity for anionic phospholipids, SS-31 preferentially distributes into cardiolipin-rich tissues including the heart, kidneys, liver, and brain.
Melanotan 1 exhibits a short systemic plasma half-life in unformulated peptide solutions—typically estimated between 30 and 60 minutes in rodent pharmacokinetic assays. However, its downstream biological signal (such as elevated intracellular cAMP and sustained eumelanin synthesis in cutaneous tissues) often persists long after the parent peptide has cleared from circulation. This duration of signal transduction is significantly extended compared to endogenous α-MSH.
Proper reconstitution protocols ensure peptide stability, prevent aggregation, and preserve target bioactivity throughout experimental assays. Researchers handling either SS-31 or Melanotan 1 should follow standardized aseptic laboratory practices.
Both SS-31 and Melanotan 1 are supplied as lyophilized (freeze-dried) powders. SS-31 is highly hydrophilic due to its basic basic amino acid composition and readily dissolves in sterile bacteriostatic water, 0.9% sodium chloride, or phosphate-buffered saline (PBS) at pH 7.4. Melanotan 1 is similarly soluble in aqueous buffers, though initial dissolution in sterile water or a weak acetic acid solution (0.1%) may be preferred if preparing high-concentration stock solutions to prevent hydrophobic self-aggregation.
Prior to liquid handling, researchers should utilize an online reconstitution calculator to determine precise solvent volumes, stock concentrations, and aliquot sizes. Lyophilized vials should be stored at -20°C or -80°C upon receipt. Reconstituted solutions should be stored in single-use aliquots at -80°C to avoid repeated freeze-thaw cycles, which degrade peptide bond integrity.
Determining whether SS-31 or Melanotan 1 is appropriate for a given research project depends entirely on the biological system under evaluation:
1. Select SS-31 if your study design investigates: Mitochondrial respiratory chain dynamics, cardiolipin oxidation, cellular ATP preservation under hypoxia, renal ischemia-reperfusion models, cardiotoxicity assays, or age-related microvascular dysfunction.
2. Select Melanotan 1 if your study design investigates: Melanocortin receptor (MC1R/MC3R/MC4R) signaling cascades, cutaneous melanogenesis, UV-damage repair mechanisms, or systemic neuroendocrine responses mediated by α-MSH analogs.
Attempting to cross-apply these compounds will lead to uninformative experimental control groups, as SS-31 exhibits zero measurable affinity for melanocortin receptors, and Melanotan 1 does not localize to or stabilize inner mitochondrial membrane cardiolipin.
When designing comparative research panels, investigators frequently group peptides by target organelle or receptor super-class. Within mitochondrial research, SS-31 is often compared against mitochondrial-derived peptides like MOTS-c, which regulates metabolic homeostasis via AMPK pathways rather than direct lipid membrane binding.
In melanocortin receptor research, Melanotan 1 is evaluated alongside related synthetic analogs such as Melanotan 2 and PT-141 (Bremelanotide). While Melanotan 1 acts predominantly as an MC1R selective agonist for pigmentation studies, Melanotan 2 and PT-141 display broader central nervous system activity via potent MC3R and MC4R activation, making them preferred subjects for central appetite, energy expenditure, and behavioral signaling models.
By structuring multi-arm preclinical trials that include these related compounds, labs can dissect specific receptor-mediated versus organelle-targeted cellular responses.
Rigorous scientific data depends on reference materials of uncompromising purity. Impurities such as truncated peptide sequences, TFA salts, heavy metals, or bacterial endotoxins can confound cell culture viability assays and animal model data.
At PX1 Research, every production lot of SS-31 and Melanotan 1 undergoes strict quality control testing in ISO 17025 accredited, GMP-compliant facilities within the USA. Each lot is verified via High-Performance Liquid Chromatography (HPLC) to confirm ≥98% chemical purity and Mass Spectrometry (MS) to confirm precise molecular mass.
Furthermore, our compounds undergo routine chromogenic LAL endotoxin testing to guarantee compatibility with sensitive in vitro cell lines and in vivo animal models. All orders ship same-day (Monday through Friday) from our CA and AZ facilities. Principal investigators and lab managers seeking volume sourcing can explore our wholesale portal for institutional accounts.
What is the primary difference between SS-31 and Melanotan 1?
SS-31 is a mitochondrial-targeted tetrapeptide that binds cardiolipin on the inner mitochondrial membrane to reduce ROS and preserve ATP. Melanotan 1 is a synthetic melanocortin receptor agonist studied for melanocortin activity related to skin pigmentation responses.
Are SS-31 and Melanotan 1 suitable for human administration?
No. Both compounds are strictly sold as research chemicals for laboratory, in vitro, and preclinical animal research use only. They are not intended for human or veterinary medical use, clinical treatment, or administration.
How should SS-31 and Melanotan 1 be stored upon arrival?
Lyophilized vials should be stored at -20°C or -80°C in a dry, dark environment. Upon reconstitution with sterile solvent, solutions should be divided into single-use aliquots and kept at -80°C to preserve peptide stability.
What solvents are recommended for reconstituting SS-31?
SS-31 is highly water-soluble and easily reconstitutes in sterile bacteriostatic water, sterile 0.9% saline, or phosphate-buffered saline (PBS) at pH 7.4.
How does Melanotan 1 differ from Melanotan 2 in preclinical studies?
Melanotan 1 is a linear peptide analog highly selective for MC1R, primarily studied for skin pigmentation responses. Melanotan 2 is a cyclic analog that crosses the blood-brain barrier more readily and binds strongly to MC3R and MC4R, influencing central signaling.
What analytical documentation accompanies PX1 Research peptides?
Every lot is supplied with a downloadable Certificate of Analysis (COA) detailing HPLC purity results (≥98%), Mass Spectrometry identity verification, and endotoxin assay levels.
What is the half-life of SS-31 in animal models?
In preclinical rodent models, SS-31 demonstrates a plasma elimination half-life of approximately 2 to 4 hours, with rapid tissue distribution to cardiolipin-dense organs like the heart and kidneys.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research peptides are manufactured in USA-based GMP-compliant facilities and shipped directly from distribution centers located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.